MedaSystems Secures Seed Financing to Modernize Global Access to Investigational Medicine
MedaSystems, developer of the only purpose-built pharma-physician network to provide patients with access to pre-approval medicine*, today announced the completion of a seed funding round.
- MedaSystems, developer of the only purpose-built pharma-physician network to provide patients with access to pre-approval medicine*, today announced the completion of a seed funding round.
- The MedaSystems SaaS platform streamlines collaboration between medical affairs, clinical operations, regulatory and shipping teams internally, and physicians and their staff, externally, enabling the rapid processing of treatment inquiries and capture of real-world data.
- The platform provides significant benefits to various stakeholders:
Sponsors (pharmaceutical manufacturers) gain significant processing speed and efficiency. - The platform enables the capture of real-world data which speeds drug discovery, expedites regulatory submission and informs the design of more effective clinical trials.